Your Source for Venture Capital and Private Equity Financings

Cedilla Therapeutics Inks $82.6M Series B

CAMBRIDGE, MA, Cedilla Therapeutics has raised $82.6 million in Series B.
Cedilla Therapeutics, a precision oncology biotechnology company, has raised an additional $25 million in an expansion of its Series B financing, bringing the total amount raised to $82.6 million.

The oversubscribed Series B expansion includes new investors RA Capital Management, Janus Henderson Investors, Woodline Partners LP and Logos Capital, along with participation from existing investor Third Rock Ventures.
(c)2011-2020 by Massinvestor, Inc. For contact info, please check out our about page.
>> Click here for in-depth research on 9,000 startups and 5,000 VC investors

Featured Reading